Tag: GLP-1 receptor agonist

Posted on by

Mazdutide and Hepatic Metabolism: Glucagon Co-Agonism, Liver Fat, and Energy Expenditure

3D visualization of dual receptor signaling on a hepatocyte membrane promoting lipid metabolism and mitochondrial oxidation.

Mazdutide combines GLP-1 and glucagon receptor agonism to target hepatic lipid clearance, basal energy expenditure, and systemic weight reduction in metabo

Read more Mazdutide and Hepatic Metabolism: Glucagon Co-Agonism, Liver Fat, and Energy Expenditure

Posted on by

Semaglutide: Myths vs. Evidence on Body Composition and Metabolic Research

Microscopic view of striated skeletal muscle tissue and adipocyte lipid droplets highlighting metabolic pathways.

A rigorous scientific breakdown separating myths from published clinical evidence on how semaglutide influences body composition, skeletal muscle preservat

Read more Semaglutide: Myths vs. Evidence on Body Composition and Metabolic Research

Posted on by

Survodutide Studies: Evaluating Dual GLP-1 and Glucagon Agonism in Clinical Research

3D scientific rendering of a dual agonist peptide binding to GLP-1 and glucagon cell surface receptors.

Survodutide is an investigational dual GLP-1 and glucagon receptor agonist undergoing clinical evaluation for obesity and metabolic dysfunction-associated

Read more Survodutide Studies: Evaluating Dual GLP-1 and Glucagon Agonism in Clinical Research

Posted on by

Semaglutide as a Research Peptide Compound: Mechanisms, Pharmacokinetics, and Empirical Evidence

3D molecular visualization of semaglutide peptide structure binding to a biological receptor in a scientific research laborat

A comprehensive scientific overview of semaglutide using the Minto Pyramid framework, examining its structural stability, receptor pharmacology, and eviden

Read more Semaglutide as a Research Peptide Compound: Mechanisms, Pharmacokinetics, and Empirical Evidence